Translational Development Acquisition Corp. | SPAC Research

Translational Development Acquisition Corp.

Status: Live Deal

U=S+W/2 W=S@11.50

IPO Proceeds, $M	$172.50M
IPO Date	Dec 23, 2024
CEO	Michael B. Hoffman
Left Lead	BTIG
IPO Cash in Trust	101.0%
SPAC Tenor	18 months
IPO Sector	Healthcare ▶
IPO Geography	Global
Target Company	ProLogium
Deal Announced	May 27, 2026
Deal Size, $M	$4,246.60M
Deal Sector	Industrial
Deal Geography	Global
SEC Filings	www.sec.gov
Approval Vote	TBD
Amendment Vote	Jun 17, 2026

TDAC TDACU TDACW

Price	$10.80
Last closing price	$10.77
H/L, today	$10.70 / $10.80
H/L, 52-week	$10.58 / $16.87
Volume, today	34,526
Volume, 3-month avg.	N/A

Price	$12.70
Last closing price	$15.22
High/low price, today	$11.82 / $13.75
High/low price, 52-week	$11.85 / $25.69
Volume, today	2,534
Volume, 3-month avg.	N/A

Price	$1.42
Last closing price	$1.55
High/low price, today	$1.35 / $1.55
High/low price, 52-week	$0.22 / $4.18
Volume, today	60,922
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.